PleuraFlow Shown to Enable Improved Outcomes for Cardiac Surgery Patients in New Clinical Study Results

Reduction of Patient Complications After Heart Surgery Demonstrated with Use of the ClearFlow’s PleuraFlow ACT System   Irvine, CA – October 20, 2020  — ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results presented at the 2020 Virtual Program of the Annual Eastern Cardiothoracic Surgical Society Conference (ECTSS) on October 8th.  The trial evaluated the use of the ClearFlow’s PleuraFlow® Active Clearance Technology® (ACT®) System in the prevention of retained blood complications in heart surgery patients.   The findings, titled “Better Pericardial Drainage After Cardiac Surgery Leads to Better Outcomes,” were presented by Dr. Meghan Kelly of the Division of Cardiothoracic Surgery at Washington University School of